No photo of M Maral Mouradian

View Scopus Profile

M Maral Mouradian

 https://orcid.org/0000-0002-9937-412X
  • 13102 Citations
  • 59 h-Index
1986 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where M Maral Mouradian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

PP2A Dysregulation in the Pathogenesis of alpha-Synucleinopathies

Mouradian, M. M. & Nicholls, R.

National Institutes of Health

5/1/17 → 4/30/22

Project: Research project

    • Developing Novel RNA-Based Therapeutics for Parkinson's Disease

    Mouradian, M. M. & Disney, M.

    National Institutes of Health

    12/15/16 → 11/30/20

    Project: Research project

    • MOLECULAR REGULATION OF TRANSMITTER RECEPTOR GENES

    Mouradian, M. M. & Chase, T.

    National Institutes of Health

    Project: Research project

    • Synergistic Neuroprotective Mechanisms of Coffee Components in Parkinson's Diseas

    Mouradian, M. M. & Stock, J.

    National Institutes of Health

    9/30/12 → 8/31/18

    Project: Research project

    • Manipulating Gene Expression in the Dyskinesias of Parkinson's Disease

    Mouradian, M. M. & Papa, S.

    National Institutes of Health

    9/1/11 → 7/31/18

    Project: Research project

    • Research Output

    Apoptosis signal regulating kinase 1 deletion mitigates α-synuclein pre-formed fibril propagation in mice

    Zhang, J., Park, E. S., Park, H. J., Yan, R., Grudniewska, M., Zhang, X., Oh, S., Yang, X., Baum, J. & Mouradian, M. M., Jan 2020, In : Neurobiology of Aging. 85, p. 49-57 9 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA

    Zhang, P., Park, H. J., Zhang, J., Junn, E., Andrews, R. J., Velagapudi, S. P., Abegg, D., Vishnu, K., Costales, M. G., Childs-Disney, J. L., Adibekian, A., Moss, W. N., Mouradian, M. M. & Disney, M. D., Jan 21 2020, In : Proceedings of the National Academy of Sciences of the United States of America. 117, 3, p. 1457-1467 11 p.

    Research output: Contribution to journal › Article

    Open Access
    • 3 Scopus citations

    Increased Dynamics of α-Synuclein Fibrils by β-Synuclein Leads to Reduced Seeding and Cytotoxicity

    Yang, X., Williams, J. K., Yan, R., Mouradian, M. M. & Baum, J., Dec 1 2019, In : Scientific reports. 9, 1, 17579.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    Letter from the Editor-in-Chief: Growth of the Journal

    Mouradian, M. M., Oct 1 2019, In : Neurotherapeutics. 16, 4, 1 p.

    Research output: Contribution to journal › Editorial

    Open Access

    Nucleic Acid–Based Therapeutics for Parkinson’s Disease

    Nakamori, M., Junn, E., Mochizuki, H. & Mouradian, M. M., Apr 15 2019, In : Neurotherapeutics. 16, 2, p. 287-298 12 p.

    Research output: Contribution to journal › Review article

    • 6 Scopus citations